Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly
- PMID: 16886969
- DOI: 10.1111/j.1365-2265.2006.02584.x
Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly
Abstract
Background: This analytical, retrospective study was designed to select cut-off thresholds of mean GH levels during a diurnal profile and nadir GH levels after oral glucose tolerance test (OGTT) according to age to diagnose surgical remission of acromegaly.
Methods: One hundred forty-one patients (76 women, aged 44 +/- 15 years and 65 men, aged 43 +/- 13 years) were included in this study. For the purpose of this study, remission was based on insulin-like growth factor-I (IGF-I) levels in the normal range for age. Diagnostic accuracy was analysed by receiving-operator characteristics (ROC) curves in the entire series, and in young (20-40 years), middle-aged (41-60 years) and older patients (> 60 years), separately.
Results: Sixty patients (42.6%) had normal IGF-I levels after surgery. In the entire series, in young and in middle-aged patients, the ROC analysis showed that optimum cut-off for mean GH levels was 2.3 microg/l (diagnostic accuracy range, 94-97%) whereas that for nadir GH after OGTT were, respectively, 0.85, 0.9 and 0.8 microg/l (diagnostic accuracy range, 90-95%). In the older patients, the optimum cut-off selected for mean GH levels was 1.4 microg/l and that for nadir GH after OGTT was 0.5 microg/l (diagnostic accuracy, 100% for both). The comparative analysis of the ROC curves did not show any significant difference between mean GH and nadir GH after OGTT (P = 0.21).
Conclusions: The criteria currently accepted for diagnosing post-surgical remission of acromegaly have high diagnostic accuracy only in the patients aged below 60 years. In older patients, lower cut-offs (i.e. = 1.4 microg/l for fasting GH and = 0.5 microg/l for nadir GH after OGTT) predict normal IGF-I levels. Mean GH levels during a diurnal profile have similar diagnostic accuracy of nadir GH levels after OGTT. This suggests that OGTT is not necessary to establish surgical cure.
Similar articles
-
Discordant nadir GH after oral glucose and IGF-I levels on treated acromegaly: refining the biochemical markers of mild disease activity.Horm Metab Res. 2010 Jan;42(1):50-5. doi: 10.1055/s-0029-1239522. Epub 2009 Oct 1. Horm Metab Res. 2010. PMID: 19798623
-
Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?Clin Endocrinol (Oxf). 2005 Apr;62(4):410-7. doi: 10.1111/j.1365-2265.2005.02233.x. Clin Endocrinol (Oxf). 2005. PMID: 15807870
-
Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.Acta Neurochir (Wien). 2005 May;147(5):485-93; discussion 493. doi: 10.1007/s00701-005-0511-9. Epub 2005 Apr 4. Acta Neurochir (Wien). 2005. PMID: 15806331 Clinical Trial.
-
Are there alternative tests for diagnosis of acromegaly?J Endocrinol Invest. 2005;28(11 Suppl International):73-4. J Endocrinol Invest. 2005. PMID: 16625850 Review.
-
GH and mortality in acromegaly.J Endocrinol Invest. 2005;28(11 Suppl International):75-7. J Endocrinol Invest. 2005. PMID: 16625851 Review.
Cited by
-
Growth hormone values after an oral glucose load do not add clinically useful information in patients with acromegaly on long-term somatostatin receptor ligand treatment.Endocrine. 2014 Feb;45(1):122-7. doi: 10.1007/s12020-013-9996-9. Epub 2013 Jun 21. Endocrine. 2014. PMID: 23794116
-
Assessment of biochemical control of acromegaly during treatment with somatostatin analogues by oral glucose load and insulin-like growth factor I.J Endocrinol Invest. 2011 Oct;34(9):e291-5. doi: 10.3275/7802. Epub 2011 Jun 21. J Endocrinol Invest. 2011. PMID: 21697649
-
The endocrine tumor summit 2008: appraising therapeutic approaches for acromegaly and carcinoid syndrome.Pituitary. 2010 Sep;13(3):266-86. doi: 10.1007/s11102-009-0210-2. Pituitary. 2010. PMID: 20012914 Free PMC article. Review.
-
Reevaluation of Acromegalic Patients in Long-Term Remission according to Newly Proposed Consensus Criteria for Control of Disease.Int J Endocrinol. 2014;2014:581594. doi: 10.1155/2014/581594. Epub 2014 Dec 21. Int J Endocrinol. 2014. PMID: 25587273 Free PMC article.
-
Dynamic tests for the diagnosis and assessment of treatment efficacy in acromegaly.Pituitary. 2008;11(2):129-39. doi: 10.1007/s11102-008-0113-7. Pituitary. 2008. PMID: 18418712 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources